Clinical Trial

MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory

VANCOUVER, BC / ACCESSWIRE / August 1, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical…

2 years ago

Glaukos Announces Second Quarter 2024 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…

2 years ago

Glaukos Announces Second Quarter 2024 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…

2 years ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

RANCHO CUCAMONGA, CA / ACCESSWIRE / July 31, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…

2 years ago

Writer Releases State-of-the-Art Specialized LLMs to Revolutionize Healthcare and Financial Services AI Applications

#1 Benchmarked Palmyra-Med-70b and Palmyra-Fin-70b now available as open models on NVIDIA API catalog, Baseten, and Hugging Face, empowering developers…

2 years ago

FloraWorks Announces Peer-Reviewed Publication of Groundbreaking Sleep Study on TruCBN(TM)

TruCBN(TM) is the first cannabinoid proven to be a safe and effective sleep aid in the largest blinded, randomized, placebo-controlled…

2 years ago

Sona Nanotech to Arrange Private Placement Financing

Halifax, Nova Scotia--(Newsfile Corp. - July 31, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is…

2 years ago

inPhronesis Announces Name Change to inThought Labs

The new name highlights the combined capabilities of decision support expertise and advanced technology solutions ORLANDO, Fla., July 30, 2024…

2 years ago